Wavelength Pharmaceuticals

Wavelength Pharmaceuticals


Company description

Wavelength Pharmaceuticals is the independent API company of choice for pharmaceutical industry leaders that require advanced API solutions to gain sustainable, competitive advantages. We are on the same wavelength. A partner in tune with the results required to better support your needs. Founded in Israel in 1987, having more than 250 customers in 50 countries, Wavelength employs a highly skilled team with all the expertise you require to advance your products to market, now, and well into the future. Our cGMP-compliant facility is a first-class operation recognized for excellence in safety, and environmental stewardship having more than 30 years of exceptional regulatory track record with leading global regulatory authorities such as USFDA, EU-EMA, PMDA, TGA, KFDA, ANVISA and COFEPRIS. We are experts in complex chemistry, innovative process development, crystalline forms and particle design and we offer customized solutions to meet individual customer requirements including full spectrum API CDMO services from pre-clinical grams to multi-ton commercial scale.

Visit our website and contact us to learn more about our products and capabilities.

Wavelength Pharmaceuticals - Always Aligned! 

Quick facts

Sales markets Western Europe; Eastern Europe; Asia; Australia; North America; Central/South America
Affiliated categories: Generic Hormones & Synthetic Substances |Generic APIs More

Upcoming events

5 may 2020

CPhI North America 2020

5 - 7 May 2020 Philadelphia, USA Visit us at stand 1408 Book a meeting See our Exhibitor Profile   See full Exhibitor List
13 oct 2020

CPhI Worldwide 2020

13 - 15 October 2020 Milan, Italy Visit us at stand 20H80 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 40F43 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with Wavelength Pharmaceuticals